WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿ ५.२०
०.००%
(०.००) 1D
अक्टोबर १५, १६:४०:०० GMT+७ · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WUXI06...
Open
฿ ५.२५
High
฿ ५.३५
Low
฿ ५.०५
Mkt. cap
१.९८ खरब
Avg. vol.
९३.६० हजार
Volume
२.८९ लाख
52-wk high
฿ ६.२५
52-wk low
฿ ३.०२
Shares outstanding
४.१२ अरब
No. of employees
१५ हजार
Open
฿ ५.२५
High
฿ ५.३५
Low
฿ ५.०५
Mkt. cap
१.९८ खरब
Avg. vol.
९३.६० हजार
Volume
२.८९ लाख
52-wk high
฿ ६.२५
52-wk low
฿ ३.०२
Shares outstanding
४.१२ अरब
No. of employees
१५ हजार
News stories
From web sources and news partners
medwatch.com
·
१ घण्टा पहिले
Iambic Therapeutics raises USD 150m in Nasdaq IPO
The Globe and Mail
·
४१ मिनेट पहिले
TNL Mediagene Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance
·
२७ मिनेट पहिले
What iShares Core S&P 500 ETF (IVV) Bought: NVIDIA Leads on Oct. 14
Seeking Alpha
·
४६ मिनेट पहिले
Dow Jones Bullish Catch-Up Over Nasdaq 100 As AI Rotation Accelerates
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics (Cayman) Inc. KKPS DR